Home
About
Overview
Sharing Data
ORCID
Help
History (1)
Novel use of an established agent: Topotecan is anti-angiogenic in experimental Wilms tumor.
See All Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Novel use of an established agent: Topotecan is anti-angiogenic in experimental Wilms tumor.
Novel use of an established agent: Topotecan is anti-angiogenic in experimental Wilms tumor. J Pediatr Surg. 2001 Dec; 36(12):1781-4.
View in:
PubMed
subject areas
Angiogenesis Inhibitors
Animals
Dose-Response Relationship, Drug
Drug Administration Schedule
Female
Mice
Mice, Nude
Neovascularization, Pathologic
Topotecan
Wilms Tumor
authors with profiles
Jessica J. Kandel